A Study Of Triphaladya Churna In The Treatment Of Urine Retention In Benign Prostatic Hyperplasia

Phase 2/3

Not yet recruiting

• Conditions: Other specified urinary incontinence. Ayurveda Condition: VATASHTHILA,

• Registration Number: CTRI/2023/02/049992
• Lead Sponsor: SHUBHAM SHARMA

Brief Summary

This is a Single Arm Clinical Study in which Triphaladya churna with Luke warm water will be carried out on 32  pre- diagnosed patients of Vatashthila ( Benign Prostatic Hyperplasia) for relieving urine retention due to BPH. Follow- ups  will be on 7th and 15th day and total duration of the study will be 15 days. The age group taken for the study will be 45 years and upto 80 years.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2022-12-23
• Study Start: 2023-03-15

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: Male
• Target Recruitment: 32

Inclusion Criteria

• A) K/C/O Vatashthila.
• B) Patient having any of 3 sign & symptoms of disease like incomplete emptying, frequency, intermittency,urgency,weak stream, straining and nocturia.
• C) Male patient, irrespective of socio- economic status.

Exclusion Criteria

• a) Bladder neck stenosis, bladder diverticulum, neurogenic bladder, neoplasm of bladder, urethral stricture.
• b) Patients with malignancy of prostate c) Patient with associated disease like T.B. , Leprosy, Venereal disease ,immuno- compromised.
• d) Patient with major complication like uremia , septicemia , shock, renal failure.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To observe the efficacy of Triphaladya churna in the management of urine retention in Vatashthila (Benign Prostatic Hyperplasia)	Triphaladya churna oral administration 1 karsha with lukewarm water twice a day for 15 days. | Follow-up will be on 7th and 15th day. | Total duration of study will be 15 days.

Secondary Outcome Measures

Name	Time	Method
1) To provide safe and cost effective treatment	for relieving urine retention in benign prostatic hyperplasia.

Trial Locations

Locations (1)

DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE PIMPRI PUNE 18; 🇮🇳 Pune, MAHARASHTRA, India

DR D Y PATIL COLLEGE OF AYURVED AND RESEARCH CENTRE PIMPRI PUNE 18

🇮🇳Pune, MAHARASHTRA, India

DR SHUBHAM SHARMA

Principal investigator

6377635801

shubhamsharma05659@gmail.com